On February 29, 2024, Elanco Animal Health Incorporated sent communication to its employees regarding a press release from one of its shareholders, Ancora Holdings Group. The Company stated that it has collaborated with these types of investors in the past and will continue to gather shareholder feedback. The Company stated that it remains focused on advancing its strategy to deliver its 3 priority outcomes in 2024 ?

Growth, Innovation, and Cash. The Company added that it has regularly engage with its shareholders and are always open to ideas that may support its success. The Company also stated that to date, it has only had 2 meetings with Ancora Holdings, and it has continually denied a more productive dialogue.

The Company stated that it would continue its efforts to engage with Ancora Holdings and to review its director candidates. The Company added that it is committed to acting in the best interest of the Company and will present recommendations regarding director nominations in the Company?s annual proxy statement to shareholders in the coming months.